JAK 억제제와 함께하는 심부정맥혈전증의 위험 조사: FDA 이상사례 보고 시스템 데이터베이스(FAERS)를 통한 비례 분석

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Baricitinib plus Remdesivir for Hospitalized Adults with Covid-192020 · 1,915 citations
2. 2Safety Profile of Levonorgestrel: A Disproportionality Analysis of Food and Drug Administration Adverse Event Reporting System (Faers) Database.2018 · 5 citations
3. 3Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA2018 · 55 citations
4. 4OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications2016 · 253 citations
5. 5Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?2017 · 104 citations